Rather than simply recreating what we already do today with notes, simple databases and spreadsheets, new technologies allow for totally new workflows, efficiencies, integration, reporting and analysis....
Report: 1 in 5 will rebound after Paxlovid, but it still works
By
Kristen Fischer
Nov 14, 2023
One in five people who take nirmatrelvir/ritonavir (Paxlovid) get COVID-19 again after the drug clears them of it, according to a new study.